Todd Carter
8Patents
5h-index
16Co-inventors
56Inventor score
Filing activity: Aug 25, 2006 → Jun 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7998971B2 | Combinations containing a 4-acylaminopyridine derivative | Human Necessities | 69 | Active |
| US7985756B2 | Modulation of neurogenesis by PDE inhibition | Human Necessities | 28 | Active |
| US7678363B2 | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs | Human Necessities | 11 | Active |
| US7858611B2 | Neurogenesis by modulating angiotensin | Human Necessities | 8 | Active |
| US7678808B2 | 5 HT receptor mediated neurogenesis | Human Necessities | 8 | Active |
| US11512327B2 | Compositions and methods for delivery of AAV | Chemistry; Metallurgy | 2 | Active |
| US12305189B2 | Compositions and methods for delivery of AAV | Chemistry; Metallurgy | 0 | Active |
| US12291565B2 | Tau binding compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.